company background image
500087 logo

Cipla BSE:500087 Stock Report

Last Price

₹1.48k

Market Cap

₹1.2t

7D

1.8%

1Y

18.5%

Updated

24 Dec, 2024

Data

Company Financials +

500087 Stock Overview

Engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. More details

500087 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends5/6

My Notes

Capture your thoughts, links and company narrative

Cipla Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cipla
Historical stock prices
Current Share Price₹1,475.90
52 Week High₹1,702.00
52 Week Low₹1,231.85
Beta0.36
1 Month Change-0.70%
3 Month Change-10.18%
1 Year Change18.51%
3 Year Change58.12%
5 Year Change208.48%
Change since IPO1,648.70%

Recent News & Updates

Recent updates

Shareholder Returns

500087IN PharmaceuticalsIN Market
7D1.8%0.6%-4.2%
1Y18.5%40.2%19.4%

Return vs Industry: 500087 underperformed the Indian Pharmaceuticals industry which returned 40.2% over the past year.

Return vs Market: 500087 matched the Indian Market which returned 19.4% over the past year.

Price Volatility

Is 500087's price volatile compared to industry and market?
500087 volatility
500087 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 500087 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 500087's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193527,764Umang Vohrawww.cipla.com

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.

Cipla Limited Fundamentals Summary

How do Cipla's earnings and revenue compare to its market cap?
500087 fundamental statistics
Market cap₹1.19t
Earnings (TTM)₹44.75b
Revenue (TTM)₹262.64b

26.6x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500087 income statement (TTM)
Revenue₹262.64b
Cost of Revenue₹89.70b
Gross Profit₹172.94b
Other Expenses₹128.19b
Earnings₹44.75b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)55.41
Gross Margin65.85%
Net Profit Margin17.04%
Debt/Equity Ratio0.6%

How did 500087 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

25%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:31
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cipla Limited is covered by 74 analysts. 37 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited